[{"address1": "2051 Ringwood Avenue", "city": "San Jose", "state": "CA", "zip": "95131", "country": "United States", "phone": "408 457 3700", "website": "https://www.ranitherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.", "fullTimeEmployees": 140, "companyOfficers": [{"maxAge": 1, "name": "Mr. Mir A. Imran", "age": 66, "title": "Executive Chairman", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 80000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Talat  Imran", "age": 41, "title": "CEO & Director", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 450000, "exercisedValue": 0, "unexercisedValue": 9180}, {"maxAge": 1, "name": "Mr. Svai S. Sanford", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 416000, "exercisedValue": 0, "unexercisedValue": 5173}, {"maxAge": 1, "name": "Dr. Mir  Hashim", "age": 63, "title": "Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 416000, "exercisedValue": 0, "unexercisedValue": 5427}, {"maxAge": 1, "name": "Mr. Eric  Groen", "age": 52, "title": "General Counsel", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Bella  Vazquez", "title": "Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kate  McKinley M.B.A.", "age": 46, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Arvinder  Dhalla", "title": "Vice President of Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 3.74, "open": 3.84, "dayLow": 3.82, "dayHigh": 4.2, "regularMarketPreviousClose": 3.74, "regularMarketOpen": 3.84, "regularMarketDayLow": 3.82, "regularMarketDayHigh": 4.2, "beta": 0.258, "forwardPE": -5.186667, "volume": 27020, "regularMarketVolume": 27020, "averageVolume": 148424, "averageVolume10days": 61900, "averageDailyVolume10Day": 61900, "bid": 3.8, "ask": 3.97, "bidSize": 100, "askSize": 100, "marketCap": 201042992, "fiftyTwoWeekLow": 1.82, "fiftyTwoWeekHigh": 8.75, "fiftyDayAverage": 5.483, "twoHundredDayAverage": 3.584275, "currency": "USD", "enterpriseValue": 105288056, "floatShares": 12709504, "sharesOutstanding": 26303900, "sharesShort": 783201, "sharesShortPriorMonth": 1238161, "sharesShortPreviousMonthDate": 1714435200, "dateShortInterest": 1717113600, "sharesPercentSharesOut": 0.0298, "heldPercentInsiders": 0.48880002, "heldPercentInstitutions": 0.13966, "shortRatio": 5.84, "shortPercentOfFloat": 0.0596, "impliedSharesOutstanding": 51682000, "bookValue": 0.281, "priceToBook": 13.843417, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -33081000, "trailingEps": -1.29, "forwardEps": -0.75, "pegRatio": 0.39, "enterpriseToEbitda": -1.678, "52WeekChange": -0.05352795, "SandP52WeekChange": 0.24598539, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "RANI", "underlyingSymbol": "RANI", "shortName": "Rani Therapeutics Holdings, Inc", "longName": "Rani Therapeutics Holdings, Inc.", "firstTradeDateEpochUtc": 1627651800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "5ed5bf18-2fc9-357f-8d44-03f1c0fe19bf", "messageBoardId": "finmb_242425883", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.89, "targetHighPrice": 15.0, "targetLowPrice": 8.0, "targetMeanPrice": 11.13, "targetMedianPrice": 11.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 39581000, "totalCashPerShare": 1.505, "ebitda": -62735000, "totalDebt": 35410000, "quickRatio": 2.972, "currentRatio": 3.095, "debtToEquity": 243.619, "returnOnAssets": -0.53029, "returnOnEquity": -1.72955, "freeCashflow": -24633124, "operatingCashflow": -48484000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-27"}]